Oxford BioMedica Loses TroVax Partner but Gets New Sanofi Deal
Oxford BioMedica plc has to start shopping around for a new partner for its TroVax therapeutic cancer vaccine after Paris-based Sanofi-Aventis dropped the late-stage program as part of a sweeping pipeline makeover. But the good news is that the Oxford, UK-based firm signed a new [...]